Remote Jobs at Sironax

Sironax

51 - 200 employees

Founded 2017

🧬 Biotechnology

💊 Pharmaceuticals

💰 $200M Series B - Sironax on 2022-08

Biotechnology • Pharmaceuticals

Sironax is a clinical-stage biopharmaceutical company developing transformative therapies for neurodegenerative, inflammatory, immunologic, and metabolic diseases. The company focuses on targeting fundamental contributors to degeneration and aging—such as disrupted energy homeostasis, dysregulated cell death, and uncontrolled inflammation—across multiple organs and tissues. Sironax advances a pipeline of first-in-class and potentially best-in-class assets, including multiple clinical-stage small-molecule programs and large-molecule therapeutics enabled by a proprietary Brain Delivery Module platform. Recent programs noted in public communications include a SARM1 inhibitor (SIR2501), which received FDA Fast Track designation for chemotherapy-induced peripheral neuropathy (CIPN), and research into NAMPT activation.